{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-036364","form_type":"8-K","ticker":"IVF","cik":"0001417926","company_name":"INVO Fertility, Inc.","filed_at":"2023-10-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.994971+00:00","generated_at":"2026-06-10T03:52:59.478019+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"INVO Bioscience enters $1.5M revenue loan agreement with Decathlon Alpha V LP","bullets":["Loan amount $1,500,000, maturity June 29, 2028.","First-priority lien on substantially all assets of INVO and its subsidiaries.","Interest factor ranges from 35% to 100% of principal based on repayment timing.","Proceeds: $300k to repay Cedar Advance, remainder for working capital.","Subsidiaries guaranteed; subordination agreements with CEO, CFO related parties."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-036364","json":"https://secwatch.observer/filing/0001493152-23-036364.json","markdown":"https://secwatch.observer/filing/0001493152-23-036364.md","text":"https://secwatch.observer/filing/0001493152-23-036364.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223036364/0001493152-23-036364-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223036364/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T03:52:59.478019+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"91d1d31e0efd94063c31857cf5829613898a9769","claim":"INVO Fertility, Inc. incurred loan of $1,500,000 with Decathlon Alpha V LP at based on a minimum amount that increases from thirty five percent (35%) of the L maturing June 29, 2028.","evidence_excerpt":"under which the Lender made a revenue loan advance in the gross amount of $1,500,000","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223036364/0001493152-23-036364-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$1,500,000"},{"label":"Counterparty","value":"Decathlon Alpha V LP"},{"label":"Rate","value":"based on a minimum amount that increases from thirty five percent (35%) of the L"},{"label":"Maturity","value":"June 29, 2028"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"2613273da1f290e9868bff2abe21408ab4a3c57a","claim":"INVO Fertility, Inc. entered into Revenue Loan and Security Agreement with Decathlon Alpha V LP valued at $1,500,000 (effective 2023-09-29).","evidence_excerpt":"On September 29, 2023, INVO Bioscience, Inc. (the “Company”), Steven Shum, as a Key Person, and the Company’s wholly-owned subsidiaries Bio X Cell, Inc, INVO Centers, LLC, Wood Violet Fertility LLC, Fertility Labs of Wisconsin LLC and Orange Blossom Fertility LLC as guarantors (the “Guarantors”), entered into a Revenue Loan and Security Agreement (the “Loan Agreement”) with Decathlon Alpha V LP (the “Lender”) under which the Lender made a revenue loan advance in the gross amount of $1,500,000 (the “Loan”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223036364/0001493152-23-036364-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Decathlon Alpha V LP"},{"label":"Value","value":"$1,500,000"},{"label":"Effective","value":"2023-09-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}